Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from a shareholder on 24th November, 2022, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Baleshwar Sahu 3341 200 31135 - 31136 70533301 - 70533500
25-11-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has issued duplicate share certificate in respect of Share Certificates reported to be lost by the shareholder. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are as given below: Name of the Shareholder Folio no. No. of shares Old Certificate Nos. Distinctive Nos. New Certificate No. Ramdas Debnath 1980 200 16753 - 16754 69095101 - 69095300 209387 This is for your information and record.
25-11-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosure Of Related Party Transactions

 Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 30th September, 2022.
07-11-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022

 This is to inform that the Board of Directors of the Company has, at its meeting held on Friday, 4th November, 2022 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter & half year ended 30th September, 2022, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter & half year ended 30th September, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.30 p.m. and ended at 5.25 p.m.
04-11-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from a shareholder on 1st November, 2022, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Ramdas Debnath 1980 200 16753 - 16754 69095101 - 69095300 This is for your information and record.
02-11-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2022

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Friday, 4th November, 2022, to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2022.
20-10-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Statement Of Investor Complaints For The Quarter Ended September 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0660 Name of the Signatory :- Priya RanjanDesignation :- Company Secretary and Compliance Officer
13-10-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliance Certificate For The Half Year Ended 30Th September, 2022

 Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the compliance certificate for the half year ended 30th September, 2022.
10-10-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st October, 2022 till 48 hours after the declaration of un-audited financial results for the quarter and half year ending 30th September, 2022. The date of the Board Meeting to consider the un-audited financial results for the quarter and half year ending 30th September, 2022, shall be intimated separately.
26-09-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 We wish to inform you that the 34th Annual General Meeting ('AGM') of the Company was held on 23rd September, 2022, through Video Conferencing and Other Audio Visual Means and the business mentioned in the Notice dated 8th August, 2022, was transacted. In this regard, enclosed please find the following- (1) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations - Annexure - I; and (2) Report of Scrutinizer dated 24th September, 2022, pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014 - Annexure- II.
24-09-2022
Next Page
Close

Let's Open Free Demat Account